Breather Trainer Versus Pulmonary Rehabilitation on Cardiopulmonary Efficiency

Horus University80 enrolled

Overview

The purpose of the study is to determine the difference between The Breather respiratory muscle trainer and pulmonary rehabilitation in patients with COPD post COVID-19.

The main concern in post COVID-19 patients is the involvement of respiratory system and cardiovascular system which may result in dyspnea, low blood oxygen saturation, and decrease cardiopulmonary efficiency. In cases of post COVID-19 patients with COPD their state is deconditioned and more critical than normal to be either in the zone of progression or regression or stability as the studies showed that handling of these cases during (3-6 months post-COVID) will prevent these symptoms from becoming permanent.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

COVID-19 COPD

Interventions

The breather respiratory muscle trainerOTHER

The breather respiratory muscle training device is a high quality and effective trainer designed to specifically train the inspiratory and expiratory muscles in one same breathing action. The device allows for adjustable levels of resistance using easy-to-read dials, which allows you to adjust the device to the settings you require. The inhale settings allow for adjustment 1-6 with 1 being the easiest and 6 being the hardest, while the exhale settings allow for adjustment 1-5, where 1 in the easiest and 5 the hardest.

Diaphragmatic and localized breathing exercisesOTHER

A. Diaphragmatic breathing exercises: Exercise will be performed as prescribed in the clinical guidelines for 5-10 minutes about 3-4 times per day. B. Localized Breathing: Exercise will be performed as prescribed in the clinical guidelines for 5-10 minutes about 3-4 times per day. C. Mild Interval training exercise

Eligibility

Sex: ALLMin age: 30 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. SPO2 ≥ 93% 2. Their age ranges from 30-40 years old. 3. COPD patients GOLD1 (Mild FEV1≥80% predicted) and GOLD2 (Moderate 50% ≤FEV1\<80%predicted) (Manian, 2019) 4. patients diagnosed as post COVID-19 Pneumonia between 3 and 6 Months ago with CT scan and PCR testing. 5. Their body mass index (BMI) ranged from 20 to 29.9kg/m2. 6. Stable medical cases with dyspnea Exclusion Criteria: Patients who will meet one of the following criteria will be excluded from the study: 1. patients with cardiac problems e.g. atrial fibrillation, left bundle-branch block, heart failure. 2. Sever cases of COPD (FEV1/FVC\< 50%) 3. Mitral or aortic valvular disease, pericardial effusion. 4. Recent myocardial infarction.

Locations (1)

Outpatient clinic, Faculty of Physical Therapy, Horus University, Egypt

Damietta, Egypt

Outcomes

Primary Outcomes

Assessment of change in Physical Fitness Index (PFI)

To assess the change in Physical Fitness Index (PFI) By using Modified Harvard Step Test (HST): The test will be done on a step height of 33 cm height. PFI was calculated by using following formula